by admin | Feb 16, 2016 | Archive
February 16, 2016 Express Scripts officials say they are carefully scrutinizing prescriptions for products made by Valeant Pharmaceuticals International, making sure the PBM’s rules are being followed. “We are looking at every single claim for their... by admin | Feb 16, 2016 | Archive
February 16, 2016 Glucagon-like peptide 1 (GLP-1) analogues are licensed for type 2 diabetes, but they could also be effective in treating patients with non-alcoholic steatohepatitis. To test this, researchers injected the long-acting GLP-1 analogue liraglutide into... by admin | Feb 16, 2016 | Archive
February 16, 2016 Under revised language proposed by FDA, companies no longer have to “provide adequate labeling” for non-FDA-approved uses of their products that they know about. Patient advocates worry that companies will use the new rule to avoid liability for... by admin | Feb 16, 2016 | Archive
February 16, 2016 CVS Pharmacy has agreed to pay $8 million to the United States to resolve claims that its pharmacies in Maryland violated the Controlled Substances Act (CSA) by dispensing controlled substances pursuant to prescriptions that were not issued for a... by admin | Feb 16, 2016 | Archive
February 16, 2016 Forty-three pharmacists across the country are being recognized for their outstanding contributions to the profession of pharmacy by Upsher-Smith Laboratories and the National Alliance of State Pharmacy Associations (NASPA). The 2015 NASPA Excellence... by admin | Feb 16, 2016 | Archive
February 16, 2016 People with type 2 diabetes are susceptible to cardiovascular and renal events, but health groups are divided about which antihypertensive agent offers optimal protection against associated outcomes. Some—including the American Diabetes Association...